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Whilst the role of TLOs is still yet to be fully elucidated in diseases such as atherosclerosis, there is evidence that like SLOs, they can contribute to immune disease progression. 5 For example, B cells in TLOs within lungs of patients with rheumatoid arthritis produce rheumatoid factor and antibodies against citrullinated proteins that are found in patients with this disease. 6 Also, disruption of TLOs in a model of autoimmune diabetes prevents formation of autoaggressive T cells and progression of diabetes, 7 and their disruption in salivary glands in a model of Sjogren's disease leads to partial restoration of salivary function. 
. 12 Like the association of TLOs with age and advanced atherosclerotic lesions, 11 M1 macrophages are also most abundant in aged ApoE 2/2 mice with advanced lesions 13 and are associated with high expression of TNF-a and lymphotoxin-a (LT-a). They firmly establish the importance of M1 macrophages in TLO formation by demonstrating that vascular smooth muscle cells activated by conditioned media from M1 macrophages and implanted subcutaneously into mice in Matrigel result in TLO-like structures containing T and B cells. They also demonstrate that TNF-a and LT-a as well as conditioned medium from macrophages stimulate vascular smooth muscle cells to secrete chemokines CXCL16, CCL19 and CCL20. Previous in vitro studies also using cultured mouse medial aortic smooth muscle cells indicate that combined TNFR-1 and LTbR signalling induces smooth muscle cells to differentiate into LTo-like cells which express a pattern of chemokines required for TLO formation.
14 Surprisingly, they find that blockade of TNFR1 and TNFR2 but not LTbR attenuated their secretion. Rather than using LTbR-Ig to antagonize LT-a, they perform orthotopic transplantation of aorta from LTbR 2/2 mice into ApoE 2/2 mice to confirm their in vitro findings, demonstrating that transplanted aortic segments from LTbR 2/2 mice still develop adventitial lymphoid structures containing T-and B-cell-rich areas together with a LYVE-1+ lymphatic system associated with atherosclerotic lesions. To further support a major role for TNF-a, they demonstrate that neutralizing TNF-a decreases germinal centre B cells and adventitial TLOs. Unfortunately they did not elucidate the cellular source of TNF-a responsible for these effects. While macrophages are major producers of TNF-a, B-cell-derived TNF-a, both membrane-bound and soluble forms, also play a key role in germinal
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centre formation with T-cell-derived TNF-a providing a complementary signal. 15 The most important findings of the present investigation is the identification of M1 macrophages as the cells responsible for activating medial vascular smooth muscle cells to secrete chemokines that lead to adventitial TLOs associated with advanced atherosclerotic lesions. These appear to be macrophages within atherosclerotic lesions secreting TNF-a and LT-a. Whilst a role for LTbR receptor signalling is definitively excluded, it is likely that both TNFa and LT-a participate. LT is expressed in either membrane-bound or secreted forms; the secreted form (LT-a) binds both TNFR1 and TNFR2 with high affinity, receptors the authors have implicated in TLO formation. In contrast the transmembrane heterotrimeric form (one LT-a plus two LT-b) selectively binds to LTbR with high affinity; 16 TNF-a also binds to TNFR1 and TNFR2 but not LTbR. Earlier studies demonstrating that LTbR-Ig suppress TLOs in atherosclerotic ApoE 2/2 mice do not exclude a role for TNFR1/TNFR2 signalling; 11 rather they demonstrate roles for LT.
Whether LTbR-Ig treatment has effects on TNF-a expression similar to LT-a gene deletion remains to be determined. While the current study has significantly advanced our understanding of mechanisms involved in development of TLOs in atherosclerotic aorta, important questions remain. It is still unclear how cytokines and chemokines produced by cells within TLOs -dendritic cells, T and B cells contribute to organization of TLOs; surface lymphotoxin expressed by B cells is critical for organization of SLOs. Also, do interactions between mature CD4+ T cells with dendritic cells contribute to adventitial TLO development? The present study provides no insight as to why TLOs are largely restricted to abdominal aorta; is this related to aortic media thickness or other properties of the aorta? Finally, the identification of M1 macrophages as LTi-like cells is a major step in our ability to specifically modulate TLO development and ultimately, gain novel insights into the pathophysiological significance of TLOs in advanced atherosclerotic lesions. Figure 1 Schematic representation of development of TLOs in atherosclerotic abdominal aorta. During chronic inflammation M1 macrophages acting similarly to lymphoid tissue inducers within atherosclerotic lesions produce TNF-a and LT-a which interact with TNFR1 and TNFR2 expressed by medial vascular smooth muscle cells. In response to this stimulus smooth muscle cells acting similarly to lymphoid tissue organizers produce chemokines which include CCL19, CCL20, and CXCL13, attracting B and T lymphocytes and also dendritic cells to the adventitia, thereby stimulating formation of TLOs.
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